Literature DB >> 32190315

Infantile macrocephaly and multiple subcutaneous lipomas diagnosed with PTEN hamartoma tumor syndrome: A case report.

Yuka Yotsumoto1,2, Atsuko Harada2,3, Jiro Tsugawa4, Yoshihiro Ikura5, Hidetsuna Utsunomiya6, Satoko Miyatake7,8, Naomichi Matsumoto7, Yonehiro Kanemura9,10, Tomoko Hashimoto-Tamaoki2.   

Abstract

A heterozygous loss-of-function mutation of the PTEN gene, one of the tumor suppressor genes, causes a wide variety of disorders, ranging from macrocephaly/autism syndrome to PTEN hamartoma tumor syndrome, including Cowden disease that causes thyroid and breast cancer mainly in the adolescence and young adult generation. An 8-month-old male infant with simple macrocephaly developed a café-au-lait spot and two subcutaneous tumors at the age of 1 year. One of the tumors developed rapidly was resected at the age of 1 year and 9 months and identified as benign lipoma. From the age of 2 years, the patient often threw a tantrum. At the age of 2 years and 9 months, a pathogenic germline mutation was identified in the PTEN gene (NM_000314.7), c.195C>A, p.Y65* in the form of a heterozygous germline variant. Developmental delay was noted but no tumors were found in the thyroid gland and breasts. Immunohistochemistry for PTEN in the resected lipoma demonstrated that the PTEN expression pattern was similar to that in a subcutaneous adipose tissue from a normal subject, suggesting that two-hit was not likely involved in the rapid growth of this lipoma. At the age of 5 years, the patient was diagnosed with autism spectrum disorders with moderate developmental delay. A long-term follow-up is underway to examine developmental changes in psychomotor disorders and possible tumor formation. Copyright: © Yotsumoto et al.

Entities:  

Keywords:  Cowden syndrome; PTEN; PTEN hamartoma tumor syndrome; autism spectrum disorder; lipoma; macrocephaly

Year:  2020        PMID: 32190315      PMCID: PMC7058917          DOI: 10.3892/mco.2020.1988

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  20 in total

1.  PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes.

Authors:  Kyle C Kurek; Emily Howard; L B Tennant; Joseph Upton; Ahmad I Alomari; Patricia E Burrows; Kim Chalache; David J Harris; Cameron C Trenor; Charis Eng; Steven J Fishman; John B Mulliken; Antonio R Perez-Atayde; Harry P W Kozakewich
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

2.  PTEN hamartoma tumour syndrome: early tumour development in children.

Authors:  Patroula Smpokou; Victor L Fox; Wen-Hann Tan
Journal:  Arch Dis Child       Date:  2014-08-11       Impact factor: 3.791

3.  A retrospective chart review of the features of PTEN hamartoma tumour syndrome in children.

Authors:  Emily Hansen-Kiss; Sarah Beinkampen; Brent Adler; Thomas Frazier; Thomas Prior; Steven Erdman; Charis Eng; Gail Herman
Journal:  J Med Genet       Date:  2017-05-19       Impact factor: 6.318

4.  A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands.

Authors:  Min-Han Tan; Jessica Mester; Charissa Peterson; Yiran Yang; Jin-Lian Chen; Lisa A Rybicki; Kresimira Milas; Holly Pederson; Berna Remzi; Mohammed S Orloff; Charis Eng
Journal:  Am J Hum Genet       Date:  2010-12-30       Impact factor: 11.025

5.  Bannayan-Riley-Ruvalcaba syndrome: MRI neuroimaging features in a series of 7 patients.

Authors:  R Bhargava; K J Au Yong; N Leonard
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-01       Impact factor: 3.825

6.  Lifetime cancer risks in individuals with germline PTEN mutations.

Authors:  Min-Han Tan; Jessica L Mester; Joanne Ngeow; Lisa A Rybicki; Mohammed S Orloff; Charis Eng
Journal:  Clin Cancer Res       Date:  2012-01-15       Impact factor: 12.531

7.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

8.  Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly.

Authors:  Gail E Herman; Eric Butter; Benedicta Enrile; Matthew Pastore; Thomas W Prior; Annemarie Sommer
Journal:  Am J Med Genet A       Date:  2007-03-15       Impact factor: 2.802

9.  The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly.

Authors:  Elizabeth A Varga; Matthew Pastore; Thomas Prior; Gail E Herman; Kim L McBride
Journal:  Genet Med       Date:  2009-02       Impact factor: 8.822

Review 10.  PTEN Hamartoma Tumor Syndrome: A Clinical Overview.

Authors:  Robert Pilarski
Journal:  Cancers (Basel)       Date:  2019-06-18       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.